Study Information

Title: A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer External
Status: Recruiting participants
Conditions: Renal Cell Carcinoma; Pharmacokinetics of AGS-16M8F
Interventions: Drug: AGS-16M8F
Institutions: Dana-Farber Cancer Institute
Health Topics: Kidney Cancer

Contact Information


Dana-Farber Cancer Institute
Boston, MA 02115